Home Coronavirus COVID-19 AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant February 7, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR VIDEO: ‘Out with Lemus’: Governor Booed at Hospital Inauguration with Sheinbaum in Tlajomulco Municipal Police Officer Arrested in US, Accused of Sexually Abusing Daughter in Jalisco ‘No Invasion’: Sheinbaum Downplays Trump Order Targeting Cartels United Airlines Restores Flights After US Nationwide Ground Stop Caused by Tech Glitch Important Meeting for SSA Recipients: Direct Deposit Changes in Mexico
